^
    No biomarker
    Small Lymphocytic Lymphoma
    zanubrutinib
    Sensitive
    :
    A1
    BeiGene Press Release - 1wk
    No biomarker
    Small Lymphocytic Lymphoma
    ICP-022
    Sensitive
    :
    A1
    No biomarker
    Small Lymphocytic Lymphoma
    rituximab + ibrutinib
    Sensitive
    :
    A1
    No biomarker
    Small Lymphocytic Lymphoma
    venetoclax
    Sensitive
    :
    A1
    No biomarker
    Small Lymphocytic Lymphoma
    idelalisib
    Sensitive
    :
    A1
    No biomarker
    Small Lymphocytic Lymphoma
    ibrutinib
    Sensitive
    :
    A1
    No biomarker
    Small Lymphocytic Lymphoma
    acalabrutinib
    Sensitive
    :
    A1
    No biomarker
    Small Lymphocytic Lymphoma
    PCR
    Sensitive
    :
    A2
    No biomarker
    Small Lymphocytic Lymphoma
    FCR
    Sensitive
    :
    A2
    No biomarker
    Small Lymphocytic Lymphoma
    alemtuzumab
    Sensitive
    :
    A2
    No biomarker
    Small Lymphocytic Lymphoma
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Small Lymphocytic Lymphoma
    obinutuzumab
    Sensitive
    :
    A2
    TP53 mutation
    Small Lymphocytic Lymphoma
    zanubrutinib
    Sensitive
    :
    A2
    Chr del(17p)
    Small Lymphocytic Lymphoma
    zanubrutinib
    Sensitive
    :
    A2
    No biomarker
    Small Lymphocytic Lymphoma
    rituximab + idelalisib
    Sensitive
    :
    A2
    Chr del(17p)
    Small Lymphocytic Lymphoma
    rituximab
    Sensitive
    :
    A2
    TP53 mutation
    Small Lymphocytic Lymphoma
    rituximab
    Sensitive
    :
    A2
    TP53 mutation
    Small Lymphocytic Lymphoma
    ibrutinib
    Sensitive
    :
    A2
    Chr del(17p)
    Small Lymphocytic Lymphoma
    ibrutinib
    Sensitive
    :
    A2
    Chr del(17p)
    Small Lymphocytic Lymphoma
    ofatumumab
    Sensitive
    :
    A2
    TP53 mutation
    Small Lymphocytic Lymphoma
    ofatumumab
    Sensitive
    :
    A2
    Chr del(17p)
    Small Lymphocytic Lymphoma
    idelalisib
    Sensitive
    :
    A2
    TP53 mutation
    Small Lymphocytic Lymphoma
    idelalisib
    Sensitive
    :
    A2
    Chr del(17p)
    Small Lymphocytic Lymphoma
    venetoclax
    Sensitive
    :
    A2
    TP53 mutation
    Small Lymphocytic Lymphoma
    venetoclax
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES